Serum creatine phosphokinase levels and prednisone treated muscle weakness.
about
Drug treatment for facioscapulohumeral muscular dystrophyFacioscapulohumeral Dystrophy.In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy.Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.Biochemistry of muscle membranes in Duchenne muscular dystrophy.Pharmocologic therapy of dystrophy in man and animals.Delayed functional disability in dystrophic chickens receiving chemotherapy.
P2860
Q24247211-E2CBD915-E4B4-4AA6-B031-7897E493A824Q30250223-B359DAF2-DB0B-46E0-81EB-FD2BD99EC470Q36997209-EB83F6E8-C443-4FA3-B5AA-56C918E21C1AQ40170529-5B1EB210-38C4-4BE0-9F38-854F8B6F0CF4Q40217077-F873B6CC-0F86-4CFA-9550-773F312B407DQ40608368-8E228847-366A-478B-B596-76C444989056Q43692842-D1DA0354-DE94-4F93-9B62-A6AEF0815BE1
P2860
Serum creatine phosphokinase levels and prednisone treated muscle weakness.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Serum creatine phosphokinase levels and prednisone treated muscle weakness.
@en
type
label
Serum creatine phosphokinase levels and prednisone treated muscle weakness.
@en
prefLabel
Serum creatine phosphokinase levels and prednisone treated muscle weakness.
@en
P356
P1433
P1476
Serum creatine phosphokinase levels and prednisone treated muscle weakness.
@en
P2093
P356
10.1212/WNL.27.1.96
P407
P577
1977-01-01T00:00:00Z